ARTEBEN

This brand name is authorized in Nigeria.

Active ingredients

The drug ARTEBEN contains one active pharmaceutical ingredient (API):

1	Albendazole UNII F4216019LN - ALBENDAZOLE
	Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
	Read more about Albendazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-100821	Capsule	Arteben-Albendazole 400 mg Caplet CAP 400 mg 1 x 2's (in Alu-PVC blister)	Caplet Solid dosage form ARTEBEN-ALBENDAZOLE 400MG CAPLET "ALBENDAZOLE 400MG, MAIZE STARCH, MAGNESIUM STEREATE, PVPK30, MICROCRYSTALLINE CELLUOSE POWDER, SODUM STRACH GLYCOLATE, CITRIC ACID, AEROSIL " A11-100821 Drugs Nigerian Products 1Caplet 10-07-2024 ARTEMIS LABORATORIES LTD, PLOT 4, BLOCK 4, OGUN STATE HOUSING CORPORATION AND INDUSTRIAL ESTATE, OTA, Ado-Odo/Ota, OGUN 08033198927 regulatoryaffairs@artemislife.com Artemis Laboratories Limited, Plot 4, Block 4, Ogun State Housing Corporation and Industrial Estate, Ota, Ogun State, Nigeria	27/03/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CA03	Albendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-100821